Higher Health Care Value Post COVID-19

When

Thursday, Oct. 8, 2020
1:00 - 3:00 p.m. ET

Register Here!

Description

With support from the Pharmaceutical Research Manufacturers of America (PhRMA), the Research Consortium for Health Care Value Assessment (RC-HCVA) established a research Grant-Making Center aimed at funding projects that will inform efficient use of health care spending to mitigate the current public health crisis and support a more sustainable health system. The goal of the 2020 funding cycle is to advance research to support a robust, evidence-based understanding of value in health care across the full spectrum of care, particularly focused on how to use health care dollars wisely in the context and aftermath of COVID-19, and ways to cut waste to best respond to the next public health emergency. To jumpstart the RC-HCVA Grant-Making Center, we solicited thought-leaders in specified areas to produce timely research briefs. These briefs will be published by Health Affairs in a series of upcoming blogs through October 2020. The RC-HCVA will also host a webinar, facilitated by Dr. Mark Fendrick, in which the panel of researchers will share their findings and insights into these COVID-19 focused topics. There will be an opportunity for questions and answers.

Agenda

1:00 – 1:05 pm Welcome and Housing Keeping (George Miller, Project PI)
1:05 – 1:15 pm Mark Fendrick (Facilitator – This Grant Center opportunity and today’s speakers)
1:15 – 1:30 pm

The Paper Tiger

  • David Cutler, PhD: Otto Eckstein Professor of Applied Economics, Department of Economics, Harvard University
1:30 – 1:45 pm

Establishing a Value-Based “New Normal” for Telehealth

  • Christina Cutter, MD, MSc, MS: National Clinician Scholars Program, Institute for Healthcare Policy & Innovation, Department of Veterans Affairs and University of Michigan; Department of Emergency Medicine, Michigan Medicine, Ann Arbor, MI; and VA Ann Arbor Healthcare System, Department of Veterans Affairs.
  • Nicholas Berlin, MD, MPH, MS: National Clinician Scholars Program, Institute for Healthcare Policy & Innovation, Department of Veterans Affairs and University of Michigan; Section of Plastic Surgery, Department of Surgery, Michigan Medicine, Ann Arbor, MI; and Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, MI.
  • A. Mark Fendrick, MD: Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI and Center for Value-Based Insurance Design, University of Michigan, Ann Arbor, MI.
1:45 – 2:00 pm

Applying Health Technology Assessment to the Healthcare Services Sector for Covid-19

  • William Padula, PhD: Assistant Professor, Department of Pharmaceutical and Health Economics, USC School of Pharmacy
2:00 – 2:15 pm

How the Covid-19 Pandemic Has Affected Provision of Routine and Elective Services by American Healthcare Providers: Opportunities and Challenges Ahead

  • Bruce Stuart, PhD: Professor, School of Pharmacy, University of Maryland, Baltimore
2:15 – 2:30 pm

Opportunities to Improve Value in Health Following the Covid-19 Pandemic

  • Kevin Griffith, PhD: Assistant Professor, Department of Health Policy, Vanderbilt University
  • Melinda Buntin, PhD: Mike Curb Professor and Chair, Department of Health Policy, Vanderbilt University
2:30 – 2:45 pm

Research Needs Regarding Low-Value Healthcare After COVID-19

  • Jodi Segal, MD, MPH: Professor of Medicine, Epidemiology, and Health Policy and Management, Johns Hopkins University
  • Allison Oakes, PhD: Advanced Postdoctoral Fellow in Health Services Research, Crescenz Veterans Affairs Medical Center, Department of Veterans Affairs and Penn Medicine Nudge Unit, University of Pennsylvania
2:45 – 3:00 pm

Covid-19 and Health Disparities—Preparing for the Next Crisis

  • Harold Pollack, PhD: Helen Ross Professor of Social Service Administration, University of Chicago Urban Labs
  • Caroline Kelly: Master’s student, School of Social Service Administration, University of Chicago
2:40 – 3:00 pm Thank you and end of webinar by Dr. Mark Fendrick